FR2510117B1 - Nouveaux derives d'hydrazonocephem et leur application pharmacologique - Google Patents

Nouveaux derives d'hydrazonocephem et leur application pharmacologique

Info

Publication number
FR2510117B1
FR2510117B1 FR8212347A FR8212347A FR2510117B1 FR 2510117 B1 FR2510117 B1 FR 2510117B1 FR 8212347 A FR8212347 A FR 8212347A FR 8212347 A FR8212347 A FR 8212347A FR 2510117 B1 FR2510117 B1 FR 2510117B1
Authority
FR
France
Prior art keywords
hydrazonocephem
derivatives
novel
pharmacological application
pharmacological
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8212347A
Other languages
English (en)
Other versions
FR2510117A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Craf Sud
Original Assignee
Craf Sud
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Craf Sud filed Critical Craf Sud
Publication of FR2510117A1 publication Critical patent/FR2510117A1/fr
Application granted granted Critical
Publication of FR2510117B1 publication Critical patent/FR2510117B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8212347A 1981-07-21 1982-07-15 Nouveaux derives d'hydrazonocephem et leur application pharmacologique Expired FR2510117B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8123033A IT1211080B (it) 1981-07-21 1981-07-21 Idrazonocefem derivati biologicamente attivi.

Publications (2)

Publication Number Publication Date
FR2510117A1 FR2510117A1 (fr) 1983-01-28
FR2510117B1 true FR2510117B1 (fr) 1985-07-05

Family

ID=11203099

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8212347A Expired FR2510117B1 (fr) 1981-07-21 1982-07-15 Nouveaux derives d'hydrazonocephem et leur application pharmacologique

Country Status (7)

Country Link
JP (1) JPS5824589A (fr)
DE (1) DE3227284A1 (fr)
ES (1) ES514106A0 (fr)
FR (1) FR2510117B1 (fr)
GB (1) GB2102423B (fr)
IT (1) IT1211080B (fr)
PT (1) PT75281A (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT381944B (de) * 1984-04-10 1986-12-10 Biochemie Gmbh Verfahren zur herstellung von cephalosporinantibiotika
CA2783572C (fr) 2005-12-07 2016-08-09 Basilea Pharmaceutica Ag Associations utiles d'antibiotiques monobactames et d'inhibiteurs de la beta-lactamase
EP2105435A4 (fr) * 2007-01-10 2011-06-15 Mitsubishi Tanabe Pharma Corp Dérivé d'hydrazone
CN112010821A (zh) * 2020-09-29 2020-12-01 山东金城医药化工有限公司 氨噻肟酸乙酯的回收方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1208015A (en) * 1967-03-23 1970-10-07 Glaxo Lab Ltd Cephalosporins
GB1208014A (en) * 1967-03-23 1970-10-07 Glaxo Lab Ltd Cephalosporins
DK400074A (fr) 1973-10-01 1975-06-09 Ciba Geigy Ag
IT1081809B (it) * 1977-06-07 1985-05-21 Isf Spa Idrazono cefalosporine
DE2818263A1 (de) * 1978-04-26 1979-11-08 Bayer Ag Beta-lactamantibiotika

Also Published As

Publication number Publication date
GB2102423A (en) 1983-02-02
IT8123033A0 (it) 1981-07-21
JPS5824589A (ja) 1983-02-14
IT1211080B (it) 1989-09-29
FR2510117A1 (fr) 1983-01-28
DE3227284A1 (de) 1983-02-24
ES8304997A1 (es) 1983-04-01
PT75281A (en) 1982-08-01
GB2102423B (en) 1985-08-14
ES514106A0 (es) 1983-04-01

Similar Documents

Publication Publication Date Title
FR2501690B1 (fr) Derives heterocycliques du type 1,2,4-triazole, leur preparation et leur application pharmacologique
BE874202A (fr) Derives d'iminoacides cycliques et leur preparation
FR2627944B3 (fr) Groupeur d'andains
MC1220A1 (fr) Nouveaux derives d'imidazolidine
FR2498188B1 (fr) Nouveaux derives de l'indole, leur preparation et leur application comme medicaments
MA19777A1 (fr) Nouveaux derives d'arene et d'heteroarenecarboxamides .
MC1696A1 (fr) Derives d'ethylenediaminemonoamide
MC1478A1 (fr) Nouveaux derives de l'imidazoquinazoline
PT74710B (fr) Nouveaux derives d'aminoethoxy-4 isopropyl-5 methyl-2-phenol
MC1516A1 (fr) Nouveaux derives d'aziridine et de phenethanolamine
MC1410A1 (fr) Nouveaux derives de l'imidazoquinazoline
FR2512819B1 (fr) Derives de macbecine et leur preparation
FR2510117B1 (fr) Nouveaux derives d'hydrazonocephem et leur application pharmacologique
PT77953A (fr) Nouveaux derives du pyrrole orthocondense et leur preparation
FR2542733B1 (fr) Nouveaux derives de biphenyle et leur preparation
MC1387A1 (fr) Nouveaux derives de phenoxyaminopropanol et leur preparation
FR2591600B1 (fr) Derives de la glucosylmoranoline et leur preparation
FR2341568A1 (fr) Nouveaux d'homo-steroides et leur procede de preparation
BE890853A (fr) Nouveaux derives de l'apramycine
BE890873A (fr) Nouveaux derives de l'aprosamine
FR2497800B1 (fr) Nouveaux derives de nitrosouree
MA20531A1 (fr) Derives de benazole et leur preparation
BE882982A (fr) Nouveaux derives de thiazolino-azetidinones et leur preparation
LU80742A1 (fr) Nouveaux derives de 11-alcanoyl-4"-deoxy-4"-isonitrilo-oleandomyeine
FR2541288B1 (fr) Derives de 3-o-acyl-4''-deoxydesmycosine et leur production

Legal Events

Date Code Title Description
ST Notification of lapse